Serum erythropoietin levels in paroxysmal nocturnal haemoglobinuria: Implications for therapy

British Journal of Haematology

Volumn 92, Issue 4, 1996, Pages 815-817

  Mcmullin, M F ^a   Hillmen, P ^b   Elder, G E ^c   Lappin, T R J ^c   Luzzatto, L ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

erythropoietin; paroxysmal haemoglobinuria; therapy

Indexed keywords

ERYTHROPOIETIN;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; THERAPY;

EID: 0029877140     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.421961.x     Document Type: Article

References (13)

1. Bourantas, K. (1994) High-dose recombinant human erythropoietin and low dose corticosteroids for treatment of anaemia in paroxysmal nocturnal haemoglobinuria. Acta Haematologica, 91, 62-65.
2. Dacie, J.V. & Lewis, S.M. (1972) Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology and nature of the disease. Series Haematologica, 5, 3-23.
3. Erslev, A.J. (1991) Erythropoietin. New England Journal of Medicine, 324, 1339-1344.
4. Gaines Das, R.E., Milne, A., Rowley M., Gordon-Smith, E.C. & Cotes, P.M. (1992) Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemias. British Journal of Haematology, 82, 601-607.
5. Iwamoto, N., Kawaguchi, T., Nagakura, S., Hidaka, M., Horikawa, K., Kagimoto, T., Takatsuki, K. & Nakakuma, H. (1995) Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria. Blood, 85, 2228-2232.
6. Krantz, S.B. (1991) Erythropoietin. Blood, 77, 419-434.
7. Lappin, T.R.J., Elder, G.E., Taylor, T., McMullin, M.F. & Bridges, J.M. (1988) Comparison of the mouse spleen assay and a radioimmunoassay for the measurement of serum erythropoietin. British Journal of Haematology, 70, 117-120.
8. Marsh, J.C.W., Socie, G., Schrezenmeier, H., Tichelli, A., Gluckman, E., Ljungman, P., McCann, S.R., Raghavachar, A., Marin, P., Hows, J.M. & Bacigalupo, A. (1994) Haemopoietic growth factors in aplastic anaemia: a cautionary note. Lancet, 344, 172-173.
9. Maxwell, A.P. & Lappin, T.R.J. (1995) Pharmacokinetics and pharmacodynamics of r-HuEpo. Erythropoiesis: New Dimensions in the Treatment of Anaemia, Vol. 6, pp. 46-53.
10. McMullin, M.F., Lappin, T.R.J., Elder, G.E., Taylor, T. & Bridges, J.M. (1989) Serum erythropoietic activity in acute anemia: an animal model. Biochemical Medicine and Metabolic Biology, 41, 30-35.
11. Nagel, R.L., Vichinsky, E., Shah, M., Johnston, R., Spadacino, E., Fabny, M.E., Mangahas, L., Abel, R. & Stamatoyonnopoulos, G.W.F. (1993) Reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study. Blood, 81, 9-14.
12. Rotoli, B. & Luzzatto, L. (1989) Paroxysmal nocturnal haemoglobinuria. Clinical Haematology, 21, 113-138.
13. Stebler, C., Tichelli, A., Dazzi, H., Gratwohl, A., Nissen, C. & Speck, B. (1990) High-dose recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study. Experimental Hematology, 18, 1204-1208.